Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Boston Scientific
(NY:
BSX
)
84.54
+0.72 (+0.86%)
Official Closing Price
Updated: 4:10 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Boston Scientific
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Health Care Stocks Could Use A Surgical Boom — Will It Happen For Stryker, Boston Scientific, Others?
March 15, 2022
Elective procedures are recovering slowly as Covid cases decline. Will they ever boom?
Via
Investor's Business Daily
Hopeful Golden Cross Forms On Boston Scientific's Chart
March 01, 2022
If history is any guide, there may be good fortune ahead for shares of Boston Scientific (NYSE:BSX). A so-called "golden cross" has formed on its chart and, not surprisingly,...
Via
Benzinga
Lantheus Sees Composite Rating Move Up To 96; Stock Rockets To New Highs
February 28, 2022
Medical imaging Lantheus stock saw an improvement in its IBD SmartSelect Composite Rating Monday, from 93 to 96.
Via
Investor's Business Daily
Boston Scientific Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold
February 23, 2022
A Relative Strength Rating upgrade for Boston Scientific shows improving technical performance.
Via
Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
February 23, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Why Is Boston Scientific Stock Trading Lower Premarket Today?
February 02, 2022
Boston Scientific Corp (NYSE: BSX) generated
Via
Benzinga
Executives Sell More Than $210M Of 5 Stocks
February 09, 2022
Spanish stocks traded higher this morning, with the IBEX 35 Index surging to the strongest level in over two weeks. Investors, meanwhile, focused on some notable insider trades....
Via
Benzinga
What 5 Analyst Ratings Have To Say About Boston Scientific
February 03, 2022
Over the past 3 months, 5 analysts have published their opinion on Boston Scientific (NYSE:BSX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Boston Scientific Tumbles On Lackluster Guidance Despite Fourth-Quarter Beat
February 02, 2022
The company topped expectations in the fourth quarter, but guidance disappointed.
Via
Investor's Business Daily
The Daily Biotech Pulse: LogicBio Genome Editing Therapy Study Placed On Clinical Hold, Gilead Q4 Disappoints On Slowing Veklury Sales
February 02, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Boston Scientific: Q4 Earnings Insights
February 02, 2022
Boston Scientific (NYSE:BSX) reported its Q4 earnings results on Wednesday, February 2, 2022 at 06:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For February 2, 2022
February 02, 2022
Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is likely to report quarterly earnings at $1.57 per share on revenue of $24.59 billion.
Via
Benzinga
What Does Boston Scientific's Debt Look Like?
January 28, 2022
Over the past three months, shares of Boston Scientific (NYSE:BSX) increased by 0.05%. Before we understand the importance of debt, let us look at how much debt Boston...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 27, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
What Does Boston Scientific's Debt Look Like?
December 15, 2021
Shares of Boston Scientific (NYSE:BSX) decreased by 6.16% in the past three months. Before having a look at the importance of debt, let us look at how much debt Boston...
Via
Benzinga
2 Medical Device Stocks Wall Street Predicts Will Rally 35% Or More
December 09, 2021
Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices used in a range of interventional medical specialties.
Via
Talk Markets
Ominous Death Cross Forms On Boston Scientific's Chart
December 06, 2021
If history is any guide, there may be trouble ahead for shares of Boston Scientific (NYSE:BSX). A so-called "death cross" has formed on its chart and, not surprisingly, this...
Via
Benzinga
Boston Scientific Corp (BSX) Q3 2021 Earnings Call Transcript
October 27, 2021
BSX earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021
December 10, 2021
Upgrades According to JP Morgan, the prior rating for Arconic Corp (NYSE:
Via
Benzinga
Boston Scientific Q3 Earnings Comes Inline With Wall Street Expectations
October 27, 2021
Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.93 billion in Q3 of 2021, almost in line with the Wall Street estimate of $2.97 billion. Sales...
Via
Benzinga
Recap: Boston Scientific Q3 Earnings
October 27, 2021
Boston Scientific (NYSE:BSX) reported its Q3 earnings results on Wednesday, October 27, 2021 at 06:30 AM. Here's what investors need to know about the announcement....
Via
Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...
Via
Benzinga
Exposures
Product Safety
Boston Scientific's Eluvia Drug-Eluting Vascular Stent Tops Bare Metal Stents
October 06, 2021
Boston Scientific Corporation (NYSE: BSX) has announced data for the Eluvia Drug-Eluting Vascular Stent System (Eluvia stent) at the Vascular InterVentional...
Via
Benzinga
Boston Scientific Beefs Up Electrophysiology, Structural Heart Portfolio With $1.75B Baylis Deal
October 06, 2021
Boston Scientific Corporation (NYSE: BSX) has agreed to acquire Baylis Medical Company Inc for an upfront payment of $1.75 billion. The acquisition will...
Via
Benzinga
Boston Scientific Highlights Trial Data For EkoSonic System For Pulmonary Embolism
October 06, 2021
Boston Scientific Corporation (NYSE: BSX) announced results for the EkoSonic Endovascular System at the Vascular InterVentional Advances (VIVA) meeting. ...
Via
Benzinga
FDA Takes Note Of Higher Risk For Women With Stroke-Preventing Implants
September 29, 2021
The FDA informed health care providers of the potential for differences in procedural outcomes between women and men undergoing implant of a left atrial appendage...
Via
Benzinga
Exposures
Product Safety
Boston Scientific Acquires Provider Of Thrombectomy Platform In Over $300M Deal
September 21, 2021
Boston Scientific Corporation (NYSE: BSX) has agreed to acquire Devoro Medical Inc for over 300 million. Boston Scientific has been a strategic investor in...
Via
Benzinga
Boston Scientific Posts Colorectal Cancer Survival Data For Tumor-Targeting Microbeads
September 20, 2021
Boston Scientific Corporation (NYSE: BSX) announced that the EPOCH clinical trial of the TheraSphere Y-90 Glass Microspheres (TheraSphere treatment) met both primary...
Via
Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics...
Via
Benzinga
Exposures
COVID-19
'Fast Money Halftime Report' Picks For September 15
September 15, 2021
On CNBC's "Fast Money Halftime Report," Karen Firestone said Charles Schwab (NYSE: SCHW) has a lot of new young traders who have larger accounts than Robinhood...
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.